| scholarly article | Q13442814 |
| P356 | DOI | 10.1179/JOC.2008.20.6.744 |
| P698 | PubMed publication ID | 19129074 |
| P2093 | author name string | Jie Liu | |
| Ling Chen | |||
| Xiao-Jie Wang | |||
| Zeng-Qing Guo | |||
| Nan-Feng Fan | |||
| Rong-Bo Lin | |||
| P2860 | cites work | Global cancer statistics, 2002 | Q27860562 |
| Phase II study of oxaliplatin, fluorouracil, and folinic acid in locally advanced or metastatic gastric cancer patients | Q33345474 | ||
| A phase II study of biweekly oxaliplatin plus infusional 5-fluorouracil and folinic acid (FOLFOX-4) as first-line treatment of advanced gastric cancer patients | Q33366008 | ||
| Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer | Q33488159 | ||
| XELOX (capecitabine plus oxaliplatin): active first-line therapy for patients with metastatic colorectal cancer | Q33978749 | ||
| Modified therapy with 5-fluorouracil, doxorubicin, and methotrexate in advanced gastric cancer | Q34366342 | ||
| Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 Study Group | Q34572233 | ||
| Evolving chemotherapy for advanced gastric cancer | Q36348340 | ||
| Disparities in gastric cancer chemotherapy between the East and West | Q36472210 | ||
| Report of two protocol planned interim analyses in a randomised multicentre phase III study comparing capecitabine with fluorouracil and oxaliplatin with cisplatin in patients with advanced oesophagogastric cancer receiving ECF. | Q36615965 | ||
| Low-dose oxaliplatin enhances the antitumor efficacy of paclitaxel in human gastric cancer cell lines | Q40229271 | ||
| Dose-intense chemotherapy every 2 weeks with dose-intense cyclophosphamide, doxorubicin, vincristine, and prednisone may improve survival in intermediate- and high-grade lymphoma: a phase II study of the Southwest Oncology Group (SWOG 9349). | Q40578618 | ||
| Phase II trial of paclitaxel by three-hour infusion for advanced gastric cancer with short premedication for prophylaxis against paclitaxel-associated hypersensitivity reactions | Q43754196 | ||
| Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. | Q44919656 | ||
| Phase II trial of oxaliplatin, leucovorin and fluorouracil in patients with advanced carcinoma of the esophagus | Q46513089 | ||
| Phase III trial in metastatic gastroesophageal adenocarcinoma with fluorouracil, leucovorin plus either oxaliplatin or cisplatin: a study of the Arbeitsgemeinschaft Internistische Onkologie | Q46694609 | ||
| OPTIMOX1: a randomized study of FOLFOX4 or FOLFOX7 with oxaliplatin in a stop-and-Go fashion in advanced colorectal cancer--a GERCOR study | Q46900220 | ||
| Randomized Trial of Dose-Dense Versus Conventionally Scheduled and Sequential Versus Concurrent Combination Chemotherapy as Postoperative Adjuvant Treatment of Node-Positive Primary Breast Cancer: First Report of Intergroup Trial C9741/Cancer and Leu | Q57578575 | ||
| P433 | issue | 6 | |
| P921 | main subject | oxaliplatin | Q422327 |
| paclitaxel | Q423762 | ||
| P304 | page(s) | 744-748 | |
| P577 | publication date | 2008-12-01 | |
| P1433 | published in | Journal of Chemotherapy | Q15754073 |
| P1476 | title | A phase II study of 5-fluorouracil/leucovorin in combination with paclitaxel and oxaliplatin as first-line treatment for patients with advanced gastric cancer | |
| P478 | volume | 20 |
| Q33416115 | A phase 2 study of fluorouracil/leucovorin in combination with paclitaxel and oxaliplatin as a salvage treatment in patients with refractory or relapsed advanced gastric cancer |
| Q43114221 | A phase I/II study of oxaliplatin and paclitaxel in patients with non-resectable cancer of the oesophagus and adenocarcinoma of the gastro-oesophageal junction: a study of the Arbeitsgemeinschaft Internistische Onkologie |
| Q36411935 | Efficacy of paclitaxel-based doublet regimens combining with intraperitoneal chemotherapy for advanced gastric cancer with peritoneal metastasis |
| Q37588039 | Helicobacter pylori and clinical aspects of gastric cancer |
| Q53560105 | Paclitaxel combined with oxaliplatin as first-line chemotherapy for locally advanced or metastatic gastric cancer. |
| Q45966144 | The combined administration of partially HLA-matched irradiated allogeneic lymphocytes and thalidomide in advanced renal-cell carcinoma: a case report. |
Search more.